世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 ヒト白血球抗原（HLA）タイピング-世界市場シェア・ランキング、全体売上高・需要予測 2025-2031Human Leukocyte Antigen (HLA) Typing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 ヒト白血球抗原（HLA）タイピングの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されています。 ヒト白血球... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーヒト白血球抗原（HLA）タイピングの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されています。ヒト白血球抗原（HLA）タイピングは、患者とドナーが臍帯血移植や骨髄移植に適合するかどうかを判定する。ヒト白血球抗原（HLA）は私たちの体内に存在するタンパク質である。ヒトの免疫システムは、これらのマーカーを用いて、どの細胞が体内にあり、どの細胞が異物であるかを判断します。 ヒト白血球抗原（HLA）タイピングの北米市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％CAGRで、2031年までに100万ドルに達するだろう。 ヒト白血球抗原（HLA）タイピングのアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万ドルに達するだろう。 ヒト白血球抗原（HLA）タイピングのヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万ドルに達するだろう。 ヒト白血球抗原（HLA）タイピングの世界の主要企業には、Thermo Fisher Scientific、QIAGEN、Illumina、CareDx、Immucor、Bio-Rad Laboratories, Inc、F. Hoffman-La Roche Ltd、Hologic, Inc、Luminex Corporation、Biofortunaなどがあります。2024年には、世界の大手5社が売上高で約 %のシェアを占めている。 本レポートは、ヒト白血球抗原（HLA）タイピングの世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当て、包括的なプレゼンテーションを提供することを目的としています。 ヒト白血球抗原（HLA）タイピングの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量（Kユニット）と販売収益（百万ドル）で提供されます。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ヒト白血球抗原（HLA）タイピングに関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 サーモフィッシャーサイエンティフィック QIAGEN イルミナ ケアデックス イミューサー バイオ・ラッド・ラボラトリーズ F.ホフマン・ラ・ロシュ社 ホロジック社 ルミネックスコーポレーション バイオフォーチュナ ブルカー アボット タカラバイオ オミクソン シーメンス EKFダイアグノスティックス BD 富士レビオ TBGダイアグノスティックス タイプ別セグメント 試薬 機器 用途別セグメント 病院 専門クリニック その他 地域別 北米 アメリカ カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートの対象範囲、世界の総市場規模（金額、数量、価格）を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：ヒト白血球抗原（HLA）タイピングメーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章： タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでのヒト白血球抗原（HLA）タイピングの売上高、収益。各地域の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、市場規模を紹介しています。 第6章 ヒト白血球抗原（HLA）タイピングの国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Human Leukocyte Antigen (HLA) Typing Product Introduction 1.2 Global Human Leukocyte Antigen (HLA) Typing Market Size Forecast 1.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value (2020-2031) 1.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume (2020-2031) 1.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Price (2020-2031) 1.3 Human Leukocyte Antigen (HLA) Typing Market Trends & Drivers 1.3.1 Human Leukocyte Antigen (HLA) Typing Industry Trends 1.3.2 Human Leukocyte Antigen (HLA) Typing Market Drivers & Opportunity 1.3.3 Human Leukocyte Antigen (HLA) Typing Market Challenges 1.3.4 Human Leukocyte Antigen (HLA) Typing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Human Leukocyte Antigen (HLA) Typing Players Revenue Ranking (2024) 2.2 Global Human Leukocyte Antigen (HLA) Typing Revenue by Company (2020-2025) 2.3 Global Human Leukocyte Antigen (HLA) Typing Players Sales Volume Ranking (2024) 2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Company Players (2020-2025) 2.5 Global Human Leukocyte Antigen (HLA) Typing Average Price by Company (2020-2025) 2.6 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Manufacturing Base and Headquarters 2.7 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Human Leukocyte Antigen (HLA) Typing 2.9 Human Leukocyte Antigen (HLA) Typing Market Competitive Analysis 2.9.1 Human Leukocyte Antigen (HLA) Typing Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Human Leukocyte Antigen (HLA) Typing Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen (HLA) Typing as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Reagent 3.1.2 Instrument 3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type 3.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (2020-2031) 3.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (%) (2020-2031) 3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type 3.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (2020-2031) 3.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (%) (2020-2031) 3.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Specialty Clinic 4.1.3 Other 4.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application 4.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (2020-2031) 4.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (%) (2020-2031) 4.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application 4.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (2020-2031) 4.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (%) (2020-2031) 4.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region 5.1.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2020-2025) 5.1.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2026-2031) 5.1.4 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), (2020-2031) 5.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region 5.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2020-2025) 5.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2026-2031) 5.2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (%), (2020-2031) 5.3 Global Human Leukocyte Antigen (HLA) Typing Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.4.2 North America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.5.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.6.2 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.7.2 South America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.8.2 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value 6.2.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.2.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.3.2 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.4.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.5.2 China Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.5.3 China Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.6.2 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.7.2 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.8.2 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.9.2 India Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.9.3 India Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Thermo Fisher Scientific 7.1.1 Thermo Fisher Scientific Company Information 7.1.2 Thermo Fisher Scientific Introduction and Business Overview 7.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Product Offerings 7.1.5 Thermo Fisher Scientific Recent Development 7.2 QIAGEN 7.2.1 QIAGEN Company Information 7.2.2 QIAGEN Introduction and Business Overview 7.2.3 QIAGEN Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 QIAGEN Human Leukocyte Antigen (HLA) Typing Product Offerings 7.2.5 QIAGEN Recent Development 7.3 Illumina 7.3.1 Illumina Company Information 7.3.2 Illumina Introduction and Business Overview 7.3.3 Illumina Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Illumina Human Leukocyte Antigen (HLA) Typing Product Offerings 7.3.5 Illumina Recent Development 7.4 CareDx 7.4.1 CareDx Company Information 7.4.2 CareDx Introduction and Business Overview 7.4.3 CareDx Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 CareDx Human Leukocyte Antigen (HLA) Typing Product Offerings 7.4.5 CareDx Recent Development 7.5 Immucor 7.5.1 Immucor Company Information 7.5.2 Immucor Introduction and Business Overview 7.5.3 Immucor Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Immucor Human Leukocyte Antigen (HLA) Typing Product Offerings 7.5.5 Immucor Recent Development 7.6 Bio-Rad Laboratories, Inc 7.6.1 Bio-Rad Laboratories, Inc Company Information 7.6.2 Bio-Rad Laboratories, Inc Introduction and Business Overview 7.6.3 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.6.5 Bio-Rad Laboratories, Inc Recent Development 7.7 F. Hoffman-La Roche Ltd 7.7.1 F. Hoffman-La Roche Ltd Company Information 7.7.2 F. Hoffman-La Roche Ltd Introduction and Business Overview 7.7.3 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Product Offerings 7.7.5 F. Hoffman-La Roche Ltd Recent Development 7.8 Hologic, Inc 7.8.1 Hologic, Inc Company Information 7.8.2 Hologic, Inc Introduction and Business Overview 7.8.3 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.8.5 Hologic, Inc Recent Development 7.9 Luminex Corporation 7.9.1 Luminex Corporation Company Information 7.9.2 Luminex Corporation Introduction and Business Overview 7.9.3 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Product Offerings 7.9.5 Luminex Corporation Recent Development 7.10 Biofortuna 7.10.1 Biofortuna Company Information 7.10.2 Biofortuna Introduction and Business Overview 7.10.3 Biofortuna Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Biofortuna Human Leukocyte Antigen (HLA) Typing Product Offerings 7.10.5 Biofortuna Recent Development 7.11 Bruker 7.11.1 Bruker Company Information 7.11.2 Bruker Introduction and Business Overview 7.11.3 Bruker Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Bruker Human Leukocyte Antigen (HLA) Typing Product Offerings 7.11.5 Bruker Recent Development 7.12 Abbott 7.12.1 Abbott Company Information 7.12.2 Abbott Introduction and Business Overview 7.12.3 Abbott Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Abbott Human Leukocyte Antigen (HLA) Typing Product Offerings 7.12.5 Abbott Recent Development 7.13 Takara Bio Inc 7.13.1 Takara Bio Inc Company Information 7.13.2 Takara Bio Inc Introduction and Business Overview 7.13.3 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.13.5 Takara Bio Inc Recent Development 7.14 Omixon Inc 7.14.1 Omixon Inc Company Information 7.14.2 Omixon Inc Introduction and Business Overview 7.14.3 Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Omixon Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.14.5 Omixon Inc Recent Development 7.15 Siemens 7.15.1 Siemens Company Information 7.15.2 Siemens Introduction and Business Overview 7.15.3 Siemens Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 Siemens Human Leukocyte Antigen (HLA) Typing Product Offerings 7.15.5 Siemens Recent Development 7.16 EKF Diagnostics 7.16.1 EKF Diagnostics Company Information 7.16.2 EKF Diagnostics Introduction and Business Overview 7.16.3 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Product Offerings 7.16.5 EKF Diagnostics Recent Development 7.17 BD 7.17.1 BD Company Information 7.17.2 BD Introduction and Business Overview 7.17.3 BD Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.17.4 BD Human Leukocyte Antigen (HLA) Typing Product Offerings 7.17.5 BD Recent Development 7.18 Fujirebio 7.18.1 Fujirebio Company Information 7.18.2 Fujirebio Introduction and Business Overview 7.18.3 Fujirebio Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.18.4 Fujirebio Human Leukocyte Antigen (HLA) Typing Product Offerings 7.18.5 Fujirebio Recent Development 7.19 TBG Diagnostics Limited 7.19.1 TBG Diagnostics Limited Company Information 7.19.2 TBG Diagnostics Limited Introduction and Business Overview 7.19.3 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.19.4 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Product Offerings 7.19.5 TBG Diagnostics Limited Recent Development 8 Industry Chain Analysis 8.1 Human Leukocyte Antigen (HLA) Typing Industrial Chain 8.2 Human Leukocyte Antigen (HLA) Typing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Human Leukocyte Antigen (HLA) Typing Sales Model 8.5.2 Sales Channel 8.5.3 Human Leukocyte Antigen (HLA) Typing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Human Leukocyte Antigen (HLA) Typing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Human Leukocyte Antigen (HLA) Typing Product Introduction 1.2 Global Human Leukocyte Antigen (HLA) Typing Market Size Forecast 1.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value (2020-2031) 1.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume (2020-2031) 1.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Price (2020-2031) 1.3 Human Leukocyte Antigen (HLA) Typing Market Trends & Drivers 1.3.1 Human Leukocyte Antigen (HLA) Typing Industry Trends 1.3.2 Human Leukocyte Antigen (HLA) Typing Market Drivers & Opportunity 1.3.3 Human Leukocyte Antigen (HLA) Typing Market Challenges 1.3.4 Human Leukocyte Antigen (HLA) Typing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Human Leukocyte Antigen (HLA) Typing Players Revenue Ranking (2024) 2.2 Global Human Leukocyte Antigen (HLA) Typing Revenue by Company (2020-2025) 2.3 Global Human Leukocyte Antigen (HLA) Typing Players Sales Volume Ranking (2024) 2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Company Players (2020-2025) 2.5 Global Human Leukocyte Antigen (HLA) Typing Average Price by Company (2020-2025) 2.6 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Manufacturing Base and Headquarters 2.7 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Human Leukocyte Antigen (HLA) Typing 2.9 Human Leukocyte Antigen (HLA) Typing Market Competitive Analysis 2.9.1 Human Leukocyte Antigen (HLA) Typing Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Human Leukocyte Antigen (HLA) Typing Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen (HLA) Typing as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Reagent 3.1.2 Instrument 3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type 3.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (2020-2031) 3.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (%) (2020-2031) 3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type 3.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (2020-2031) 3.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (%) (2020-2031) 3.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Specialty Clinic 4.1.3 Other 4.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application 4.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (2020-2031) 4.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (%) (2020-2031) 4.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application 4.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (2020-2031) 4.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (%) (2020-2031) 4.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region 5.1.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2020-2025) 5.1.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2026-2031) 5.1.4 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), (2020-2031) 5.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region 5.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2020-2025) 5.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2026-2031) 5.2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (%), (2020-2031) 5.3 Global Human Leukocyte Antigen (HLA) Typing Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.4.2 North America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.5.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.6.2 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.7.2 South America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 5.8.2 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value 6.2.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.2.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.3.2 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.4.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.5.2 China Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.5.3 China Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.6.2 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.7.2 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.8.2 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031 6.9.2 India Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031 6.9.3 India Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Thermo Fisher Scientific 7.1.1 Thermo Fisher Scientific Company Information 7.1.2 Thermo Fisher Scientific Introduction and Business Overview 7.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Product Offerings 7.1.5 Thermo Fisher Scientific Recent Development 7.2 QIAGEN 7.2.1 QIAGEN Company Information 7.2.2 QIAGEN Introduction and Business Overview 7.2.3 QIAGEN Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 QIAGEN Human Leukocyte Antigen (HLA) Typing Product Offerings 7.2.5 QIAGEN Recent Development 7.3 Illumina 7.3.1 Illumina Company Information 7.3.2 Illumina Introduction and Business Overview 7.3.3 Illumina Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Illumina Human Leukocyte Antigen (HLA) Typing Product Offerings 7.3.5 Illumina Recent Development 7.4 CareDx 7.4.1 CareDx Company Information 7.4.2 CareDx Introduction and Business Overview 7.4.3 CareDx Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 CareDx Human Leukocyte Antigen (HLA) Typing Product Offerings 7.4.5 CareDx Recent Development 7.5 Immucor 7.5.1 Immucor Company Information 7.5.2 Immucor Introduction and Business Overview 7.5.3 Immucor Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Immucor Human Leukocyte Antigen (HLA) Typing Product Offerings 7.5.5 Immucor Recent Development 7.6 Bio-Rad Laboratories, Inc 7.6.1 Bio-Rad Laboratories, Inc Company Information 7.6.2 Bio-Rad Laboratories, Inc Introduction and Business Overview 7.6.3 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.6.5 Bio-Rad Laboratories, Inc Recent Development 7.7 F. Hoffman-La Roche Ltd 7.7.1 F. Hoffman-La Roche Ltd Company Information 7.7.2 F. Hoffman-La Roche Ltd Introduction and Business Overview 7.7.3 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Product Offerings 7.7.5 F. Hoffman-La Roche Ltd Recent Development 7.8 Hologic, Inc 7.8.1 Hologic, Inc Company Information 7.8.2 Hologic, Inc Introduction and Business Overview 7.8.3 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.8.5 Hologic, Inc Recent Development 7.9 Luminex Corporation 7.9.1 Luminex Corporation Company Information 7.9.2 Luminex Corporation Introduction and Business Overview 7.9.3 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Product Offerings 7.9.5 Luminex Corporation Recent Development 7.10 Biofortuna 7.10.1 Biofortuna Company Information 7.10.2 Biofortuna Introduction and Business Overview 7.10.3 Biofortuna Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Biofortuna Human Leukocyte Antigen (HLA) Typing Product Offerings 7.10.5 Biofortuna Recent Development 7.11 Bruker 7.11.1 Bruker Company Information 7.11.2 Bruker Introduction and Business Overview 7.11.3 Bruker Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Bruker Human Leukocyte Antigen (HLA) Typing Product Offerings 7.11.5 Bruker Recent Development 7.12 Abbott 7.12.1 Abbott Company Information 7.12.2 Abbott Introduction and Business Overview 7.12.3 Abbott Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 Abbott Human Leukocyte Antigen (HLA) Typing Product Offerings 7.12.5 Abbott Recent Development 7.13 Takara Bio Inc 7.13.1 Takara Bio Inc Company Information 7.13.2 Takara Bio Inc Introduction and Business Overview 7.13.3 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.13.5 Takara Bio Inc Recent Development 7.14 Omixon Inc 7.14.1 Omixon Inc Company Information 7.14.2 Omixon Inc Introduction and Business Overview 7.14.3 Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Omixon Inc Human Leukocyte Antigen (HLA) Typing Product Offerings 7.14.5 Omixon Inc Recent Development 7.15 Siemens 7.15.1 Siemens Company Information 7.15.2 Siemens Introduction and Business Overview 7.15.3 Siemens Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 Siemens Human Leukocyte Antigen (HLA) Typing Product Offerings 7.15.5 Siemens Recent Development 7.16 EKF Diagnostics 7.16.1 EKF Diagnostics Company Information 7.16.2 EKF Diagnostics Introduction and Business Overview 7.16.3 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Product Offerings 7.16.5 EKF Diagnostics Recent Development 7.17 BD 7.17.1 BD Company Information 7.17.2 BD Introduction and Business Overview 7.17.3 BD Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.17.4 BD Human Leukocyte Antigen (HLA) Typing Product Offerings 7.17.5 BD Recent Development 7.18 Fujirebio 7.18.1 Fujirebio Company Information 7.18.2 Fujirebio Introduction and Business Overview 7.18.3 Fujirebio Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.18.4 Fujirebio Human Leukocyte Antigen (HLA) Typing Product Offerings 7.18.5 Fujirebio Recent Development 7.19 TBG Diagnostics Limited 7.19.1 TBG Diagnostics Limited Company Information 7.19.2 TBG Diagnostics Limited Introduction and Business Overview 7.19.3 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025) 7.19.4 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Product Offerings 7.19.5 TBG Diagnostics Limited Recent Development 8 Industry Chain Analysis 8.1 Human Leukocyte Antigen (HLA) Typing Industrial Chain 8.2 Human Leukocyte Antigen (HLA) Typing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Human Leukocyte Antigen (HLA) Typing Sales Model 8.5.2 Sales Channel 8.5.3 Human Leukocyte Antigen (HLA) Typing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の医療機器・消耗品分野での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
